Article
A veteran oncology startup crew is making a very serious bet that they've found the key to unlock
Rating:
0.0
Views:
59
Likes:
1
Library:
1
Five years ago, when Amgen ushered the oncolytic virus T-Vec over the finish line at the FDA, 2 things seemed completely clear in short order. One was that an important new avenue in cancer therapy had been opened up, finding a clean shot at solid tumors while recruiting an immune
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value